Antiparasitic Agents < Antiparkinson Agents < Antipsychotic Agents

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 358.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000010 (1999)	F. Durif [France] ; M. Vidailhet ; B. Debilly ; Yves Agid [France]	Worsening of levodopa-induced dyskinesias by motor and mental tasks.
000011 (1999)	J L Montastruc [France] ; M. Ziegler ; O. Rascol ; M. Malbezin	A randomized, double-blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's disease.
000012 (1999)	L. Defebvre [France] ; P. Derambure ; J L Bourriez ; A. Destée ; J D Guieu	[Event-related desynchronization and Parkinson disease. Importance in the analysis of the phase of preparation for movement].
000013 (1998)		Ropinirole: new preparation. Wait for more convincing data.
000020 (1999)	B P Bejjani [France] ; P. Damier ; I. Arnulf ; L. Thivard ; A M Bonnet ; D. Dormont ; P. Cornu ; B. Pidoux ; Y. Samson ; Yves Agid [France]	Transient acute depression induced by high-frequency deep-brain stimulation.
000027 (1999)	P. Krack [France] ; P. Pollak ; P. Limousin ; A. Benazzouz ; G. Deuschl ; A L Benabid	From off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity.
000036 (1999)	O. Rascol [France] ; C. Brefel-Courbon ; S. Descombes ; J L Montastruc	Clinical pharmacology of levodopa-induced dyskinesia in parkinsonian patients.
000037 (1999)	P. Damier [France]	New aspects in the pathophysiology of dyskinesia. Salpêtrière Deep Brain Stimulation Group.
000042 (1999)	C. Thalamas [France] ; A. Taylor ; C. Brefel-Courbon ; S. Eagle ; K. Fitzpatrick ; O. Rascol	Lack of pharmacokinetic interaction between ropinirole and theophylline in patients with Parkinson's disease.
000047 (????)	H. Bagheri [France] ; C. Damase-Michel ; M. Lapeyre-Mestre ; S. Cismondo ; D. O'Connell ; J M Senard ; O. Rascol ; J L Montastruc	A study of salivary secretion in Parkinson's disease.
000061 (1999)	M. Vidailhet [France] ; A M Bonnet ; R. Marconi ; F. Durif ; Yves Agid [France]	The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease.
000062 (1999)	O. Rascol [France]	L-dopa-induced peak-dose dyskinesias in patients with Parkinson's disease: a clinical pharmacologic approach.
000069 (1999)	Olga Corti [France] ; Amelia Sánchez-Capelo [France] ; Philippe Colin [France] ; Naïma Hanoun [France] ; Michel Hamon [France] ; Jacques Mallet [France]	Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson’s disease
000073 (1999)	M. Gentil [France] ; C L Tournier ; P. Pollak ; A L Benabid	Effect of bilateral subthalamic nucleus stimulation and dopatherapy on oral control in Parkinson's disease.
000074 (1999)	S. Champagne [France] ; E. Coste ; H. Peyrière ; J. Nigond ; E. Mania ; M. Pons ; D. Hillaire-Buys ; P. Balmes ; J P Blayac ; J M Davy	Chronic constrictive pericarditis induced by long-term bromocriptine therapy: report of two cases.
000080 (1999)	Yves Agid [France] ; E. Ahlskog ; A. Albanese ; D. Calne ; T. Chase ; J. De Yebenes ; S. Factor ; S. Fahn ; O. Gershanik ; C. Goetz ; W. Koller ; M. Kurth ; A. Lang ; A. Lees ; P. Lewitt ; D. Marsden ; E. Melamed ; P P Michel ; Y. Mizuno ; J. Obeso ; W. Oertel ; W. Olanow ; Werner Poewe [Autriche] ; P. Pollak ; E. Tolosa	Levodopa in the treatment of Parkinson's disease: a consensus meeting.
000081 (1999)	C. Dentresangle [France] ; L. Veyre ; D. Le Bars ; C. Pierre ; F. Lavenne ; P. Pollak ; J. Guerin ; J C Froment ; E. Brousolle	Striatal D2 dopamine receptor status in Parkinson's disease: an [18F]dopa and [11C]raclopride PET study.
000083 (1999)	S. Mesure [France] ; J P Azulay ; J. Pouget ; B. Amblard	Strategies of segmental stabilization during gait in Parkinson's disease.
000085 (1999)	L. Vercueil [France] ; J P Linard ; B. Wuyam ; P. Pollak ; G. Benchetrit	Breathing pattern in patients with Parkinson's disease.
000091 (2000)	T. Boraud [France] ; E. Bezard ; J M Stutzmann ; B. Bioulac ; C E Gross	Effects of riluzole on the electrophysiological activity of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey.
000098 (2000)	P. Damier [France] ; L. Tremblay ; J. Féger ; E C Hirsch	[Development of dyskinesias induced by treatment for Parkinson's disease: potential role of first exposure to L-DOPA (or phenomenon of priming)].

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Antiparkinson Agents" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Antiparkinson Agents" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Antiparkinson Agents
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024